NeutriSci Provides Operational Update
VANCOUVER, BC – (Marketwired – May 11, 2016) – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX VENTURE: NU) the innovator and pioneer behind neuenergy™, is pleased to provide a Canadian operational update.
BuluBox.com has reported that neuenergy™ ranks near the top of their Best Seller list (BuluBox best sellers) amongst more than 1,000 online products sold through BuluBox, and, neuenergy™ was recently featured on the “Scoop”, an online video review of BuluBox.com products.
NeutriSci shipped its first Canadian nationwide order of neuenergy™ in Q1-2016, and consumer response has been very good. To date, turns in the stores that have received the product from their distributor have been better than expected. Initial launch projections and expectations were planned for 1 unit every 3 days. As of May 1st, orders into the stores are tracking at an average of 1 unit every day and continue to trend upwards, exceeding internal projections. With the recent marketing partnership with Venture Communications, the Company expects the initial marketing plan to further grow sales, drive increased awareness and brand recognition.
By the end of Q2-2016, distribution points for neuenergy™ in Canada will have increased by 156% over Q1-2016; with individual partner announcements to follow in the coming weeks. In conjunction with the increase in the Canadian distribution network, the Company will be receiving initial orders from its new partners in Q2-2016 and into Q3-2016.
NeutriSci’s President, Mr. Glen Rehman, stated, “We are thrilled with the growing response to neuenergy™ in Canada. Our current growth strategy in Canada has us on track to exceed previously stated estimates for network growth and distribution within Canada. Our partnership with Venture Communications will establish a media campaign aimed directly at enhancing the recognition of neuenergy™ in the Canadian marketplace. The resulting growth in Canada is a testament to the effectiveness of neuenergy.”
To find out more about neuenergy™, visit www.getneuenergy.com.
On Behalf of the Board of Directors of NEUTRISCI INTERNATIONAL INC.
Glen Rehman, President
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.
About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci has focused on the development of several breakthrough nutraceutical products with an initial focus on areas such as heart and cholesterol health, sleep deprivation therapies, immune defense as well as men’s prostate and sexual health. NeutriSci continues to build strong relationships and distribution channels for its BluScience™ and neuenergy™ products with retailers throughout the United States. NeutriSci is focusing efforts in strengthening sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers. For more information, visit: www.neutrisci.com.
Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.
NeutriSci International Inc.
Tel: (403) 264-6320
For investor relations inquiries:
Skanderbeg Capital Advisors
O: 604-687-7130 x105